Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down – Here’s Why

Bio-Rad Laboratories, Inc. (NYSE:BIO.B)’s share price gapped down prior to trading on Friday . The stock had previously closed at $312.75, but opened at $257.05. Bio-Rad Laboratories shares last traded at $257.05, with a volume of 43 shares.

Bio-Rad Laboratories Trading Down 12.9%

The company has a current ratio of 5.44, a quick ratio of 3.94 and a debt-to-equity ratio of 0.18. The stock has a market capitalization of $6.94 billion, a P/E ratio of 9.21 and a beta of 1.01. The business’s fifty day simple moving average is $307.35 and its two-hundred day simple moving average is $289.78.

Bio-Rad Laboratories (NYSE:BIO.B) last announced its quarterly earnings data on Thursday, February 12th. The company reported $2.51 EPS for the quarter. Bio-Rad Laboratories had a net margin of 29.42% and a return on equity of 3.95%. The business had revenue of $693.20 million during the quarter.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc is a global provider of innovative products and systems that serve the life science research and clinical diagnostics markets. The company operates through two primary segments: Life Science, which delivers instruments, consumables and software for research applications, and Clinical Diagnostics, which offers quality control materials and reagent systems for blood typing, immunology and molecular testing. Bio-Rad’s product portfolio supports a wide range of applications, including protein analysis, gene expression, cell biology and digital PCR.

In the Life Science segment, Bio-Rad develops and markets technologies such as electrophoresis and imaging systems, chromatography instruments, laboratory consumables and software platforms that streamline experimental workflows.